Hypertensive disease and pregnancy

Journal of Hypertension

Volumn 20, Issue SUPPL. 2, 2002, Pages

  Hibbard, Judith U ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Complications in pregnancy; Eclampsia; Hypertension in pregnancy; Pre eclampsia

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; DIURETIC AGENT; HYDRALAZINE; MAGNESIUM SULFATE;

CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; FEMALE; FETUS MONITORING; HUMAN; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; PERINATAL MORBIDITY; PERINATAL MORTALITY; PREECLAMPSIA; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; SYSTOLIC BLOOD PRESSURE; EVIDENCE BASED MEDICINE; HYPERTENSION; MATERNAL WELFARE; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; UNITED STATES;

EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPERTENSION; MATERNAL WELFARE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; UNITED STATES;

EID: 0036563383     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200212000-00001     Document Type: Conference Paper

References (56)

1. What's in a name problems with the classification of pre-eclampsia
2. Lack of consistency in research papers over the definition of pre-eclampsia
3. The detection, investigation, and management of hypertension in pregnancy, full consensus of recommendations from the Council of the Australasian Society for the Study of Hypertension in Pregnancy (ASSHP)
4. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy
5. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in pregnancy
6. Renal physiology and disease in pregnancy
7. Low-dose aspirin to prevent preeclampsia in women at high risk
8. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension
9. Current understanding of severe preeclampsia, pregnancy-associated haemolytic uremic syndrome, thrombotic thrembocytopenic purpura, haemolysis, elevated liver enzymes and low platelet syndrome, and postpartum acute renal failure: Different clinical syndromes or just different names
10. Pre-eclampsia: More than pregnancy induced hypertension
11. Defects in placentation and placental perfusion
12. Pathogenesis and genetics of preeclampsia
13. Recent insights into the pathogenesis of preeclampsia
14. Preeclampsia: An excessive maternal inflammatory response to pregnancy
15. Brief review: Hypertension in pregnancy; a manifestation of the insulin resistence syndrome?
16. Central hemodynamic observation in untreated preeclamptic patients
17. Serial assessment of the cardiovascular system in normal pregnancy
18. Magnesium, platelets and the vasculature in preeclampsia-eclampsia
19. Left ventricular mechanics in preeclampsia
20. Placental cytokines and pathogenesis of preeclampsia
21. Heterogeneous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications
22. Oxidative stress in the pathogenesis of preeclampsia
23. Inadequate reducing systems in pre-eclampsia. A complementary role for vitamins A and C with thioredoxin-related activities
24. Arterial circulation in pregnancy complicated by hypertension
25. Maternal hemodynamics in normal and preeclamptic pregnancies: A longitudinal study
26. Maternal central hemodynamics in hypertensive disorders of pregnancy
27. Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis
28. Renal and cardiovascular alterations
29. Control of volume and body tonicity
30. Alterations in volume homeostasis
31. Transcapillary fluid balance in pre-eclampsia
32. Pathology of kidney, liver, and brain
33. Platelet and coagulation abnormalities
34. Prevention of preeclampsia with low dose aspirin in healthy nulliparous pregnant women
35. A randomized trial of low dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women
36. Low dose aspirin to prevent preeclampsia in women at high risk
37. Antiplatelet agents for preventing and treating pre-eclampsia
38. Antiplatelet drugs for the prevention of pre-eclampsia and its consequences: Systematic review
39. Calcium supplementation to prevent hypertensive disorders of pregnancy
40. Trial of calcium for prevention of preeclampsia
41. Calcium supplementation during pregnancy for preventing hypertensive disorders of and related problems
42. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: A randomized trial
43. Overview of randomized trials of diuretics in pregnancy
44. Expectant management of severe preeclampsia remote from term
45. Aggressive or expectant management for patients with severe preeclampsia between 28-34 week's gestation: A randomized controlled trial
46. Aggressive versus expectant management of severe preeclampsia at 28-32 weeks gestation: A randomized controlled trial
47. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia
48. Anticonvulsants for women with preeclampsia
49. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial
50. The Magpie Trial: Magnesium sulphate for preeclampsia, evaluating the effects on women and their babies
51. Underlying disorders associated with severe early-onset preeclampsia
52. Severe preeclampsia in the second trimester: Recurrence risk and long-term prognosis